SCHEMBL7879836

SCHEMBL7879836

CN(C(=N)N)C(=O)c1cc2c(C(F)(F)F)ccc(Oc3cc(N)ccn3)c2[nH]1

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
BRAF P15056 10/20 0.33
MAPK8 P45983 2/20 0.33
MAPK10 P53779 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7877954 0.89 LOXL2 (0.37)
SCHEMBL7885023 0.89 PDE4A (0.36) BRAFMAPK8MAPK10
SCHEMBL7873914 0.89 BRAF (0.32) BRAFMAPK8MAPK10
SCHEMBL7873258 0.88 CYP1A2 (0.32) BRAFMAPK8MAPK10
SCHEMBL7881272 0.88 NUDT1 (0.32) BRAF
SCHEMBL7881823 0.86 SCN9A (0.30) BRAF
SCHEMBL7877765 0.86 BRAF (0.37) BRAF
SCHEMBL7880919 0.85 FFAR1 (0.36) BRAF
SCHEMBL7881379 0.84 TLR7 (0.36) BRAF
SCHEMBL7882112 0.84 BRAF (0.34) BRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6248772-B1 HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2001-06-19 US disclosed
US-6169107-B1 USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS SUMITOMO PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
EP-0708091-A2 Indoloylguanidine derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1996-04-24 EP disclosed